Menopause Hormone Therapy: 30 Years of Advances and Controversies
- 26 October 2025
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 31 (12) , 1642-1648
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetesDiabetes & Metabolism, 2024
- Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic reviewArchives of Gynecology and Obstetrics, 2022
- Association of Premature Natural and Surgical Menopause With Incident Cardiovascular DiseaseJAMA, 2019
- Duration of Menopausal Vasomotor Symptoms Over the Menopause TransitionJAMA Internal Medicine, 2015
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Usefulness of Baseline Lipids and C-Reactive Protein in Women Receiving Menopausal Hormone Therapy as Predictors of Treatment-Related Coronary EventsThe American Journal of Cardiology, 2008
- Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since MenopauseJAMA, 2007
- Estrogen Plus Progestin and Risk of Venous ThrombosisJAMA, 2004
- National Use of Postmenopausal Hormone TherapyJAMA, 2004
- Postmenopausal use of estrogen and occlusion of coronary arteriesAmerican Heart Journal, 1988